SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-052948
Filing Date
2023-06-29
Accepted
2023-06-29 16:31:04
Documents
13
Period of Report
2023-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181159-8k_silopharma.htm   iXBRL 8-K 26945
2 FIFTH AMENDMENT TO COMMERCIAL EVALUATION AND LICENSE AGREEMENT, DATED JUNE 28, 2 ea181159ex99-1_silopharma.htm EX-99.1 17023
  Complete submission text file 0001213900-23-052948.txt   220441

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE silo-20230628.xsd EX-101.SCH 2965
4 XBRL LABEL FILE silo-20230628_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE silo-20230628_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea181159-8k_silopharma_htm.xml XML 3603
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 231057830
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl